EGPAF & Unitaid Data Dashboard: Doing More, Faster
Mozambique; Côte d’Ivoire; Cameroon; Kenya; Lesotho; Rwanda; Swaziland; Zambia; Zimbabwe
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and Unitaid are sharing promising results from the early routine use of innovative point-of-care (POC) technologies for early infant diagnosis (EID) of HIV in six sub-Saharan African countries—Cameroon, Cote d’Ivoire, Lesotho, Rwanda, Swaziland, Zimbabwe. This four-year, US $63 million project aims to increase the number of HIV-positive infants whose HIV status is known in order to facilitate early antiretroviral treatment (ART) initiation.
EGPAF, with Unitaid’s support, is working hand-in-hand with ministries of health and other key stakeholders to integrate POC EID into national EID systems in nine high-prevalence countries: Cameroon, Côte d’Ivoire, Kenya, Lesotho, Mozambique, Rwanda, Swaziland, Zambia, and Zimbabwe.
To illustrate this work, real-time data on POC EID testing in the project countries is available through an interactive data dashboard, developed using Microsoft Power BI, and housed on the EGPAF website.
Visit our Point of Care Early Infant HIV Diagnosis Dashboard: www.pedaids.org/pocdashboard
The overarching goal of this project is to increase the number of HIV-positive infants whose HIV status is known in order to facilitate early ART initiation by providing HIV-exposed infants (HEI) with timely access to EID of HIV through the incorporation of POC EID into national EID testing networks.
In all project countries, POC testing for EID will be incorporated into the existing lab network in order to develop a strategic mix of both conventional and point-of-care testing and, thereby, optimize the functioning of the national EID network.
Through this project, EGPAF, with funding from Unitaid, will increase the number and percentage of infants and caregivers receiving HIV test results; decrease the turn-around time of results from test to return of result to caregiver; decrease the number of days from HIV diagnosis to ART initiation for HIV-infected infants; and increase the number of children on life-saving treatment.